Abstract
HLA-matched related (MRD) or unrelated donor (URD) nonmyeloablative conditioning and hematopoietic cell transplant (HCT) for patients with advanced Hodgkin disease (HD)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have